newsfilter
← Latest News
GlobeNewswire·

Exagen Inc. Announces Select Preliminary 2025 Financial Results

CARLSBAD, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (NASDAQ:XGN), a leading provider of autoimmune testing, today announced select preliminary unaudited financial results for the fourth quarter and year